Fontan patient Luca - transplanted after support with EXCOR® Revive

Luca, the first patient who could be saved with the new venous cannula from Berlin Heart.
Fontan patient Luca was 17 years old when he needed to be listed for a heart transplant. However, Luca had to be removed from the transplant list due to significant deterioration because of his failing Fontan palliation (massive ascites, PLE, FALD, massive sarcopenia, etc.). He was weak, immobile, and could barely keep food down.
Together with his treating physicians and his family, Luca then decided to try EXCOR® Revive as a lifesaving treatment option. Luca’s condition improved steadily on the EXCOR® Revive system. His failing Fontan symptoms dramatically improved. He regained the ability to feed himself
normally, and was soon more active and completely mobile, which meant that he could be relisted for heart transplant. After 132 days on the EXCOR® Revive system, he underwent successful donor heart implantation.
Berlin Heart is proud that our technology could contribute to saving Luca's life. We hope that our work can help even more people in the future who suffer from similar conditions.
We recommend the case report on the above-described case, which can be found at: pubmed.ncbi.nl...
++++++++++
This Video was shot at the Berlin Heart Summer Event 2022. See the Full Video here:
• Celebrating Life and C...
Find out more about EXCOR® Revive: www.berlinhear...
Find out more about Berlin Heart on www.berlinheart.de/en/   
++++++++++
The access to some or all shown products may be restricted due to country-specific regulatory
approvals. IKUS and EXCOR Active are intended for professional healthcare facility
environments only.
The use of EXCOR® VAD for adults, RVAD-support and the EXCOR® Venous Cannula are not FDA approved. EXCOR® Active is an investigational device approved for use
in a clinical study under IDE# G200252 approved by the FDA.
++++++++++
#vad #berlinheart #brigdetotransplant #entscheidedich